⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMRX News
Immuneering Corporation Class A Common Stock
Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival
globenewswire.com
IMRX
AmMax Bio Names Suneel K. Gupta, Ph.D. as Chief Scientific Officer to Advance Novel ADC Portfolio
globenewswire.com
PTGX
IMRX
Immuneering to Participate in Upcoming Investor Conferences
globenewswire.com
IMRX
Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients
globenewswire.com
IMRX
Form 8-K
sec.gov
IMRX
Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
IMRX
Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition
globenewswire.com
IMRX
Immuneering Corporation Announces Grants of Inducement Awards
globenewswire.com
IMRX
Kalaris Appoints Laurie Keating to Board of Directors
globenewswire.com
KLRS
PEPG
IMRX
Form 8-K
sec.gov
IMRX